Japan’s drug GMP audits require compliance with the Pharmaceuticals and Medical Devices Act, adherence to the Ministry of Health, Labour and Welfare (MHLW) guidelines, proper documentation, quality management systems, validated processes, and regular internal audits. Facilities must ensure product safety, efficacy, and quality, and maintain traceability and accountability throughout production.